Nicola Fazio provides overview of the current classifications and clinical implications of neuroendocrine tumours (NETs), the role of somatostatin Receptor, what is current practice and treatment of advanced GEP and lung NETs, the key prognostic and predictive factors in NETs, as well as current challenges and future perspectives in the research and treatment of NETs.

Oncology Meeting Resources

Major Sponsors

AstraZeneca Janssen Servier

Main Sponsors

Amgen Astellas Bayer Healthcare Boehringer Ingelheim Genomic Health Inc. ipsen Lilly Oncology MSD Nutricia Roche